{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:14:19Z","timestamp":1778526859388,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770185"],"award-info":[{"award-number":["31770185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970886"],"award-info":[{"award-number":["31970886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070929"],"award-info":[{"award-number":["32070929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271868"],"award-info":[{"award-number":["82271868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.115901","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T20:31:17Z","timestamp":1701808277000},"page":"115901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice"],"prefix":"10.1016","volume":"170","author":[{"given":"Shengxue","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qitao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-873X","authenticated-orcid":false,"given":"Chengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2023.115901_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.101596","article-title":"Epidemiology of hepatitis C virus infection","volume":"45","author":"Roudot-Thoraval","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2023.115901_bib2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.115901_bib3","author":"World Health Organization","year":"2017","journal-title":"Glob. Hepat. Rep."},{"key":"10.1016\/j.biopha.2023.115901_bib4","first-page":"548","article-title":"Hepatitis C virus screening practices and prevalence in a managed care organization, 2000-2007","volume":"17","author":"Roblin","year":"2011","journal-title":"Am. J. Manag Care"},{"key":"10.1016\/j.biopha.2023.115901_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2893.2010.01327.x","article-title":"Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting","volume":"18","author":"Southern","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"7 Pt B","key":"10.1016\/j.biopha.2023.115901_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3851\/IMP2470","article-title":"Rapid diagnostic HCV antibody assays","volume":"17","author":"Smith","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biopha.2023.115901_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-016-0071-z","article-title":"Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States","volume":"11","author":"Rosenthal","year":"2016","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.biopha.2023.115901_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/508295a","article-title":"Hepatitis C drugs not reaching poor","volume":"508","author":"Callaway","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115901_bib9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2016.01.001","article-title":"Hepatitis C reinfection after sustained virological response","volume":"64","author":"Midgard","year":"2016","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115901_bib10","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/ijms18081626","article-title":"Unsolved puzzles surrounding HCV immunity: heterologous immunity adds another dimension","volume":"18","author":"Agrawal","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2023.115901_bib11","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jhep.2014.09.009","article-title":"A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing","volume":"61","author":"Baumert","year":"2014","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115901_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJMoa2023345","article-title":"Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection","volume":"384","author":"Page","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2023.115901_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.dld.2004.07.004","article-title":"Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?","volume":"36","author":"Missale","year":"2004","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115901_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","article-title":"Approaches, progress, and challenges to hepatitis C vaccine development","volume":"156","author":"Bailey","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115901_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2023.115901_bib16","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115901_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.virs.2022.07.005","article-title":"HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China","volume":"37","author":"Du","year":"2022","journal-title":"Virol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115901_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(01)00245-3","article-title":"The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor","volume":"80","author":"Masciopinto","year":"2001","journal-title":"Virus Res"},{"key":"10.1016\/j.biopha.2023.115901_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-8-229","article-title":"Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation","volume":"8","author":"Ahmad","year":"2011","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.biopha.2023.115901_bib20","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"issue":"7881","key":"10.1016\/j.biopha.2023.115901_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-021-03913-5","article-title":"Structural insights into hepatitis C virus receptor binding and entry","volume":"598","author":"Kumar","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2023.115901_bib22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.32470","article-title":"A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice","volume":"76","author":"Donnison","year":"2022","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2023.115901_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02133-17","article-title":"Induction of genotype cross-reactive, hepatitis C virus-specific, cell-mediated immunity in DNA-vaccinated mice","volume":"92","author":"Wijesundara","year":"2018","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115901_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: a review","volume":"32","author":"Hadj Hassine","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115901_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01722-17","article-title":"Recombinant chimpanzee adenovirus vaccine AdC7-M\/E protects against zika virus infection and testis damage","volume":"92","author":"Xu","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115901_bib26","article-title":"Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans","volume":"5","author":"Capone","year":"2020","journal-title":"NPJ Vaccin."},{"issue":"10","key":"10.1016\/j.biopha.2023.115901_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008748","volume":"5","author":"Green","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.biopha.2023.115901_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008027","article-title":"A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection","volume":"14","author":"Luo","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115901_bib29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/22221751.2021.1931466","article-title":"Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates","volume":"10","author":"Luo","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"10.1016\/j.biopha.2023.115901_bib30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s12250-021-00434-3","article-title":"A self-biomineralized novel adenovirus vectored COVID-19 vaccine for boosting immunization of mice","volume":"36","author":"Luo","year":"2021","journal-title":"Virol. Sin."},{"issue":"13","key":"10.1016\/j.biopha.2023.115901_bib31","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/emboj\/17.13.3521","article-title":"Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants","volume":"17","author":"Puntoriero","year":"1998","journal-title":"EMBO J."},{"issue":"261","key":"10.1016\/j.biopha.2023.115901_bib32","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2023.115901_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2019.05.008","article-title":"A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development","volume":"268","author":"Luo","year":"2019","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115901_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115901_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01145","article-title":"A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice","volume":"10","author":"Masavuli","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115901_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106421","article-title":"Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection","volume":"26","author":"Deng","year":"2023","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.biopha.2023.115901_bib37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.gt.3301933","article-title":"Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3\/4A-expressing tumors in vivo","volume":"10","author":"Frelin","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2023.115901_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2016.11.011","article-title":"Tissue resident memory T cells and viral immunity","volume":"22","author":"Rosato","year":"2017","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115901_bib39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"issue":"9653","key":"10.1016\/j.biopha.2023.115901_bib40","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2023.115901_bib41","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JVI.02950-14","article-title":"Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors","volume":"89","author":"Abbink","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115901_bib42","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2019.11.282","article-title":"Antibody responses to immunization with HCV Envelope glycoproteins as a baseline for b-cell-based vaccine development","volume":"158","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115901_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00880-23","article-title":"Two novel adenovirus vectors mediated differential antibody responses via interferon-\u03b1 and natural killer cells","author":"Zou","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2023.115901_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60238-5","article-title":"Characterization of a species E adenovirus vector as a Zika virus vaccine","volume":"10","author":"Bullard","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115901_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.mt.6300024","article-title":"Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector","volume":"15","author":"Hensley","year":"2007","journal-title":"Mol. Ther."},{"issue":"19","key":"10.1016\/j.biopha.2023.115901_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00202-19","article-title":"Single-dose vaccination with a hepatotropic adeno-associated virus efficiently localizes T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus","volume":"93","author":"Mekonnen","year":"2019","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115901_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.26750","article-title":"Infection of common marmosets with hepatitis C virus\/GB virus-B chimeras","volume":"59","author":"Li","year":"2014","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.biopha.2023.115901_bib48","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1128\/JVI.02653-15","article-title":"Infection of common marmosets with GB virus B chimeric virus encoding the major nonstructural proteins NS2 to NS4A of hepatitis C virus","volume":"90","author":"Zhu","year":"2016","journal-title":"J. Virol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:38:52Z","timestamp":1773967132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"alternative-id":["S0753332223016992"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115901","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115901"}}